Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.


TSXV:CVM.H - Post by User

Bullboard Posts
Post by gamer007on Sep 06, 2019 1:36pm
179 Views
Post# 30103060

While we wait.........................!!!!!!

While we wait.........................!!!!!!Since CEO's message, I hear he is working on getting things back on track, interviewing for a couple board seats as indicated and working on getting financing in place, to accelerate trials. I don't have confirmation on trading resumption, and have emailed him with this question.

I hope all of you have taken the opportunity to call Peter and get any issues you have had resolved..................he has indicated he is more user friendly...............let's see if this plays out.

I like the content on the website, with the new committees being formed to address the issues outlined with respect to conforming to NASDAQ rules.............which were a bone of contention with old directors..................this is a change in thought process.................essential for the succes of a NASDAQ listing.

His admission that a new CEO should take the reins to move the project through to the next level is a major milestone, and I think it is an admission that  he is listening to all of us, who want change as well. However, I think it is good that he remains a director with only one voice, as he has still a lot to contribute, as well as his relationships with Cannon and other groups he has made internationally.

As painful as this has seemed...............witht he delays.........extra dilution..........cleaning the closet is always a good thing..............personally or in a corporate sense..........

What we have in our lap is a (management) people problem........... which can be resolved..................while the product has no problem..............in fact, is gaining more credibility as we speak, fron the trial people and the FDA people...........
......this is what we need to hang on to !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

I feel we have a hit a low, and that bringing new blood to the table will help restore the confidence to push the vision forward to get this device to market .............................................

........my cup is half full.............

Bullboard Posts